New hepatitis C therapies in clinical development
<p>Abstract</p> <p>With the current standard of care for the treatment of chronic hepatitis C, a combination of pegylated interferon alfa and ribavirin, sustained virologic response rates can be achieved in approximately 50% of patients only.</p> <p>Improved understanding of the viral life cycle has...
में बचाया:
| मुख्य लेखकों: | , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMC
2011-07-01
|
| श्रृंखला: | European Journal of Medical Research |
| विषय: | |
| ऑनलाइन पहुंच: | http://www.eurjmedres.com/content/16/7/303 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|